CVS HEALTH Corp Quarterly Report for Q1 Ended Mar 31, 2026

Summary

CVS Health Corporation reported a strong first quarter for 2026, demonstrating significant revenue and net income growth compared to the prior year. Total revenues increased by 6.2% to $100.4 billion, driven by robust performance across all operating segments, particularly in Health Services and Pharmacy & Consumer Wellness, with notable contributions from pharmacy drug mix and brand inflation. Net income saw a substantial increase of 65.9% to $2.96 billion. This growth was significantly aided by the absence of large one-time charges incurred in the prior year, such as the legacy litigation charge and the loss on Accountable Care assets. The effective income tax rate also improved due to these factors. The company maintained a solid liquidity position with $9.5 billion in cash and cash equivalents, and continues to return value to shareholders through consistent dividend payments.

Key Highlights

• 1Total revenues grew 6.2% year-over-year to $100.4 billion, driven by broad segment performance.
• 2Net income surged 65.9% to $2.96 billion, benefiting from the absence of prior-year charges.
• 3Operating income increased by a significant 38.7% to $4.68 billion, reflecting improved segment performance and lower one-time expenses.
• 4The Health Care Benefits segment saw strong growth in its Government business and improved Medical Benefit Ratio (MBR) to 84.6%.
• 5Health Services segment revenue increased 11.0% driven by pharmacy drug mix and brand inflation.
• 6Pharmacy & Consumer Wellness segment revenues remained stable, with positive same-store sales growth in both pharmacy and front store.
• 7The company maintained a strong liquidity position with $9.5 billion in cash and cash equivalents as of March 31, 2026.

Frequently Asked Questions